vs
Side-by-side financial comparison of PARK NATIONAL CORP (PRK) and Bio-Techne (TECH). Click either name above to swap in a different company.
Bio-Techne is the larger business by last-quarter revenue ($295.9M vs $168.3M, roughly 1.8× PARK NATIONAL CORP). PARK NATIONAL CORP runs the higher net margin — 25.3% vs 12.8%, a 12.5% gap on every dollar of revenue. On growth, PARK NATIONAL CORP posted the faster year-over-year revenue change (2.2% vs -6.4%). Over the past eight quarters, PARK NATIONAL CORP's revenue compounded faster (4.9% CAGR vs 4.2%).
National Retail Systems, Inc. (NRS) includes Keystone Freight Corp. & National Retail Transportation, Inc. (NRT). NRS is an asset based 3PL founded in 1952. It is headquartered in Lyndhurst, New Jersey, United States.
Bio-Techne Corporation is an American life sciences company that develops, manufactures and sells life science reagents, instruments and services for the research, diagnostic, and bioprocessing markets.
PRK vs TECH — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $168.3M | $295.9M |
| Net Profit | $42.6M | $38.0M |
| Gross Margin | — | 64.6% |
| Operating Margin | — | 18.4% |
| Net Margin | 25.3% | 12.8% |
| Revenue YoY | 2.2% | -6.4% |
| Net Profit YoY | 10.4% | 68.3% |
| EPS (diluted) | $2.62 | $0.24 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $168.3M | $295.9M | ||
| Q3 25 | $169.5M | — | ||
| Q2 25 | $168.7M | $317.0M | ||
| Q1 25 | $157.9M | $316.2M | ||
| Q4 24 | $164.7M | $297.0M | ||
| Q3 24 | $170.3M | $289.5M | ||
| Q2 24 | $157.7M | $306.1M | ||
| Q1 24 | $152.8M | $303.4M |
| Q4 25 | $42.6M | $38.0M | ||
| Q3 25 | $47.2M | — | ||
| Q2 25 | $48.1M | $-17.7M | ||
| Q1 25 | $42.2M | $22.6M | ||
| Q4 24 | $38.6M | $34.9M | ||
| Q3 24 | $38.2M | $33.6M | ||
| Q2 24 | $39.4M | $40.6M | ||
| Q1 24 | $35.2M | $49.1M |
| Q4 25 | — | 64.6% | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 62.7% | ||
| Q1 25 | — | 67.9% | ||
| Q4 24 | — | 65.3% | ||
| Q3 24 | — | 63.2% | ||
| Q2 24 | — | 66.4% | ||
| Q1 24 | — | 67.4% |
| Q4 25 | — | 18.4% | ||
| Q3 25 | 34.3% | — | ||
| Q2 25 | 35.2% | -7.5% | ||
| Q1 25 | 32.4% | 12.2% | ||
| Q4 24 | — | 16.0% | ||
| Q3 24 | 27.4% | 13.8% | ||
| Q2 24 | 30.6% | 15.0% | ||
| Q1 24 | 27.8% | 22.1% |
| Q4 25 | 25.3% | 12.8% | ||
| Q3 25 | 27.8% | — | ||
| Q2 25 | 28.5% | -5.6% | ||
| Q1 25 | 26.7% | 7.1% | ||
| Q4 24 | 23.5% | 11.7% | ||
| Q3 24 | 22.4% | 11.6% | ||
| Q2 24 | 25.0% | 13.3% | ||
| Q1 24 | 23.0% | 16.2% |
| Q4 25 | $2.62 | $0.24 | ||
| Q3 25 | $2.92 | — | ||
| Q2 25 | $2.97 | $-0.11 | ||
| Q1 25 | $2.60 | $0.14 | ||
| Q4 24 | $2.38 | $0.22 | ||
| Q3 24 | $2.35 | $0.21 | ||
| Q2 24 | $2.42 | $0.26 | ||
| Q1 24 | $2.17 | $0.31 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $233.5M | $172.9M |
| Total DebtLower is stronger | — | $260.0M |
| Stockholders' EquityBook value | $1.4B | $2.0B |
| Total Assets | $9.8B | $2.5B |
| Debt / EquityLower = less leverage | — | 0.13× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $233.5M | $172.9M | ||
| Q3 25 | $218.9M | — | ||
| Q2 25 | $193.1M | $162.2M | ||
| Q1 25 | $237.6M | $140.7M | ||
| Q4 24 | $160.6M | $177.5M | ||
| Q3 24 | $201.7M | $187.5M | ||
| Q2 24 | $261.5M | $152.9M | ||
| Q1 24 | $306.1M | $145.3M |
| Q4 25 | — | $260.0M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | $346.0M | ||
| Q1 25 | — | $330.0M | ||
| Q4 24 | — | $300.0M | ||
| Q3 24 | — | $300.0M | ||
| Q2 24 | — | $319.0M | ||
| Q1 24 | — | $389.0M |
| Q4 25 | $1.4B | $2.0B | ||
| Q3 25 | $1.3B | — | ||
| Q2 25 | $1.3B | $1.9B | ||
| Q1 25 | $1.3B | $2.0B | ||
| Q4 24 | $1.2B | $2.1B | ||
| Q3 24 | $1.2B | $2.1B | ||
| Q2 24 | $1.2B | $2.1B | ||
| Q1 24 | $1.2B | $2.0B |
| Q4 25 | $9.8B | $2.5B | ||
| Q3 25 | $9.9B | — | ||
| Q2 25 | $9.9B | $2.6B | ||
| Q1 25 | $9.9B | $2.6B | ||
| Q4 24 | $9.8B | $2.7B | ||
| Q3 24 | $9.9B | $2.7B | ||
| Q2 24 | $9.9B | $2.7B | ||
| Q1 24 | $9.9B | $2.7B |
| Q4 25 | — | 0.13× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 0.18× | ||
| Q1 25 | — | 0.16× | ||
| Q4 24 | — | 0.14× | ||
| Q3 24 | — | 0.14× | ||
| Q2 24 | — | 0.15× | ||
| Q1 24 | — | 0.19× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $198.3M | — |
| Free Cash FlowOCF − Capex | $191.9M | — |
| FCF MarginFCF / Revenue | 114.1% | — |
| Capex IntensityCapex / Revenue | 3.8% | — |
| Cash ConversionOCF / Net Profit | 4.65× | — |
| TTM Free Cash FlowTrailing 4 quarters | $328.2M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $198.3M | — | ||
| Q3 25 | $52.6M | — | ||
| Q2 25 | $49.7M | $98.2M | ||
| Q1 25 | $37.9M | $41.1M | ||
| Q4 24 | $178.8M | $84.3M | ||
| Q3 24 | $43.8M | $63.9M | ||
| Q2 24 | $50.9M | $75.5M | ||
| Q1 24 | $35.0M | $81.0M |
| Q4 25 | $191.9M | — | ||
| Q3 25 | $51.1M | — | ||
| Q2 25 | $48.4M | $93.3M | ||
| Q1 25 | $36.8M | $31.0M | ||
| Q4 24 | $169.7M | $77.5M | ||
| Q3 24 | $41.7M | $54.7M | ||
| Q2 24 | $49.0M | $57.5M | ||
| Q1 24 | $31.9M | $64.5M |
| Q4 25 | 114.1% | — | ||
| Q3 25 | 30.1% | — | ||
| Q2 25 | 28.7% | 29.4% | ||
| Q1 25 | 23.3% | 9.8% | ||
| Q4 24 | 103.0% | 26.1% | ||
| Q3 24 | 24.5% | 18.9% | ||
| Q2 24 | 31.1% | 18.8% | ||
| Q1 24 | 20.8% | 21.3% |
| Q4 25 | 3.8% | — | ||
| Q3 25 | 0.9% | — | ||
| Q2 25 | 0.8% | 1.5% | ||
| Q1 25 | 0.7% | 3.2% | ||
| Q4 24 | 5.6% | 2.3% | ||
| Q3 24 | 1.2% | 3.2% | ||
| Q2 24 | 1.2% | 5.9% | ||
| Q1 24 | 2.1% | 5.4% |
| Q4 25 | 4.65× | — | ||
| Q3 25 | 1.11× | — | ||
| Q2 25 | 1.03× | — | ||
| Q1 25 | 0.90× | 1.82× | ||
| Q4 24 | 4.63× | 2.42× | ||
| Q3 24 | 1.14× | 1.90× | ||
| Q2 24 | 1.29× | 1.86× | ||
| Q1 24 | 0.99× | 1.65× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
PRK
Segment breakdown not available.
TECH
| Diagnostics And Spatial Biology | $81.2M | 27% |
| EMEA Excluding UK | $75.4M | 25% |
| Other | $42.4M | 14% |
| Instruments | $29.6M | 10% |
| APAC Excluding Greater China | $22.7M | 8% |
| Services | $22.3M | 8% |
| GB | $13.7M | 5% |
| Royalty | $8.5M | 3% |
